Trinity Biotech

NASDAQ: TRIB · Real-Time Price · USD
1.58
-0.33 (-17.28%)
At close: Aug 15, 2025, 2:38 PM

Trinity Biotech Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
61.55M 56.83M 74.78M 92.97M
Cost of Revenue
40.11M 37.38M 52.73M 54.89M
Gross Profit
21.44M 19.45M 22.05M 38.08M
Operating Income
-21.16M -27.05M -10.91M 13.15M
Interest Income
n/a 1.17M 303K 1.22M
Pretax Income
-30.73M -36.93M -41.19M 751K
Net Income
-31.79M -24.02M -41M 875K
Selling & General & Admin
28.82M 31.15M 29.17M 24.68M
Research & Development
4.54M 4.38M 4.14M 4.5M
Other Expenses
9.25M 10.96M -343K -4.67M
Operating Expenses
42.61M 46.49M 32.96M 24.51M
Interest Expense
11.96M 10.15M 24.73M 7.1M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.72M 83.88M 85.69M 79.4M
Income Tax Expense
486K -59K -192K -178K
Shares Outstanding (Basic)
17.96M 7.65M 6.75M 4.18M
Shares Outstanding (Diluted)
17.96M 7.65M 7.77M 5.33M
EPS (Basic)
-1.8 -3.14 -6.08 0.20
EPS (Diluted)
-1.8 -3.14 -5.27 0.20
EBITDA
-16.91M -24.1M -16.71M 10.59M
EBIT
-18.77M -25.87M -19.05M 3.52M
Depreciation & Amortization
1.86M 1.78M 2.33M 2.74M